Absorption of vitamin K2 by dogs after oral administration of a soft gelatin capsule formulation containing a new emulsion-type vehicle

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 12, 1999, Pages 1375-1380

  Amemiya, Tohru ^a   Mizuno, Satoshi ^b   Hayashi, Yayoi ^c   Yuasa, Hiroaki ^c   Watanabe, Jun ^c  

^a Kakegawa Factory   (Japan)

^b Scientific Affairs   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; FARNOQUINONE; GELATIN; MENATETRENONE; CETOMACROGOL; MICROSPHERE; SURFACTANT; VITAMIN K GROUP;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISPERSION; DOG; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CAPSULE; EMULSION; ENCAPSULATION; FOOD; MALE; NONHUMAN; ANIMAL; BLOOD; INTESTINE ABSORPTION; ORAL DRUG ADMINISTRATION; VEHICLES;

ADMINISTRATION, ORAL; ANIMALS; CETOMACROGOL; DOGS; EMULSIONS; INTESTINAL ABSORPTION; MALE; MICROSPHERES; SURFACE-ACTIVE AGENTS; VEHICLES; VITAMIN K;

EID: 0033233142     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991777191     Document Type: Article

References (19)

1. Amemiya, T., Mizuno, S., Yuasa, H., Watanabe, J. (1998a) Development of emulsion type new vehicle for soft gelatin capsule. I. Selection of surfactants for development of new vehicle and its physicochemical properties. Chem. Pharm. Bull. 46: 309-313
2. Amemiya, T., Mizuno, S., Yuasa, H., Watanabe, J. (1998b) Emulsion type new vehicle available for preclinical and clinical trials: stability of characteristics of particle size distribution of new vehicle. Xenobio. Metab. Dispos. 13: 516-523
3. Amemiya, T., Mizuno, S., Yuasa, H., Watanabe, J. (1999) Emulsion type new vehicle for soft gelatin capsule available for preclinical and clinical trials: effects of PEG 6000 and PVP K30 on physicochemical stability of new vehicle. Chem. Pharm. Bull. 47: 492-497
4. Bateman, N. E., Uccellini, D. A. (1984) Effect of formulation on the bioavailability of retinol, D-α-tocopherol and riboflavin. J. Pharm. Pharmacol. 36: 461-464
5. Craig, D. Q. M., Lievens, H. S. R., Pitt, K. G., Storey, D. E. (1993) An investigation into the physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int. J. Pharm. 96: 147-155
6. Ghirardi, P., Catenazzo, G., Mantero, O., Merotti, G. C., Marzo, A. (1977) Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules. J. Pharm. Sci. 66: 267-269
7. Hom, F. S., Veresh, S. A., Ebert, W. R. (1975) Soft gelatin capsules II: oxygen permeability study of capsule shells. J. Pharm. Sci. 64: 851-857
8. Ishii, M., Shimomura, M., Hasegawa, J., Asano, T., Yamato, C., Yamano, Y., Inai, Y., Okano, K., Ohno, T., Yamazaki, K., Kashiwano, M., Kanamaru, M., Nakajima, M. (1995) Study on the metabolism and excretion of menatetrenone (Ea-0167), and effect of food on menatetrenone absorption. Jpn Pharmacol. Ther. 23: 225-230
9. Lesko, L. J., Canada, A. T., Eastwood, G., Walker, D., Brousseau, D. (1979) Pharmacokinetics and relative bioavailability of oral theophylline capsules. J. Pharm. Sci. 68: 1392-1394
10. Nadai, T., Kondo, R., Tatematsu, A., Sezaki, H. (1972) Drug-induced histological changes and its consequences on the permeability of the small intestinal mucosa. I. EDTA, tetracycline and sodium lauryl sulfate. Chem. Pharm. Bull. 20: 1139-1144
11. Nadai, T., Kume, M., Tatematsu, A. (1975) Drug-induced histological changes and its consequences on the permeability of the small intestinal mucosa. II. Chem. Pharm. Bull. 23: 543-551
12. Pouton, C. W. (1985) Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification. Int. J. Pharm. 27: 335-348
13. Ritschel, W. A. (1991) Microemulsions for improved peptide absorption from the gastrointestinal tract. Methods Find. Exp. Clin. Pharmacol. 13: 205-220
14. Ritschel, W. A., Adolph, S., Ritschel, G. B., Schroeder, T. (1990) Improvement of peroral absorption of cyclosporine A by microemulsions. Methods Find. Exp. Clin. Pharmacol. 12: 127-134
15. Sano, Y., Tadano, K., Kikuchi, K., Kaneko, K., Yuzuriha, T. (1993) Pharmacokinetic characterization of menaquinone-4 in dogs by sensitive HPLC determination. J. Nutr. Sci. Vitaminol. 39: 555-566
16. Shah, N. H., Carvajal, M. T., Patel, C. I., Infeld, M. H., Malick, A. W. (1994) Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm. 106: 15-23
17. Shino, M. (1988) Determination of endogenous vitamin K (phylloquinone and menaquinone) in plasma by high-performance liquid chromatography using platinum oxide catalyst reduction and fluorescence detection. Analyst 113: 393-397
18. Uematsu, T., Nagashima, S., Niwa, M., Kohno, K., Sassa, T., Ishii, M., Tomono, Y., Yamato, C., Kanamaru, M. (1996) Effect of dietary fat content on oral bioavailability of menatetrenone in humans. J. Pharm. Sci. 85: 1012-1016
19. Yamashita, Y., Noguchi, T., Noguchi, T., Takenaka, H., Maeda, T. (1979) Absorption of diazepam from a lipid-containing oral dosage form. Chem. Pharm. Bull. 27: 1190-1198